CHANGZHOU, China, April 30, 2012 /PRNewswire-Asia-FirstCall/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2011 with the United States Securities and Exchange Commission on April 30, 2012.

The Company's annual report on Form 20-F contains its audited consolidated financial statements and is available on the Company's website at http://ir.kanghui.com. The Company will provide a hard copy of its completed audited financial statements free of charge to its shareholders and ADS holders upon request.

About China Kanghui Holdings

Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine, and has an extensive nationwide network of distributors for its products in China, as well as in 28 other countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products and product lines, and enhancing existing products and product lines. For more information, please visit www.kanghui.com.

Contact:

China Kanghui Holdings Investor Relations Department 
+1-888-321-2558

Asia Bridge Capital Limited
Carene Toh
+86-186 1835 6339
carene.toh@asiabridgegroup.com

SOURCE China Kanghui Holdings